Pazolong 400mg Tablet
Marketer
MSN Laboratories
Salt Composition
Pazopanib (400mg)
Overview Pazolong 400mg Tablet
KinaseGuard 400mg tablets are a protein kinase inhibitor indicated for kidney cancer and soft tissue sarcoma. Administer KinaseGuard 400mg on an empty stomach, consistently at the same time daily for optimal efficacy. Dosage and frequency are determined by your physician based on your condition and may be adjusted. Strict adherence to your physician's instructions is crucial; incorrect usage or overdose can lead to severe adverse reactions. Therapeutic effects may not be apparent for weeks or months; discontinue only under medical supervision. Common side effects include elevated blood pressure and diarrhea. Your doctor may recommend regular blood pressure checks. Manage diarrhea with increased fluid intake or consult your physician if persistent. This medication can reduce blood cell counts, increasing infection risk. Report fever, flu-like symptoms, or shortness of breath immediately. Prior to starting treatment, disclose any pre-existing heart, liver, or kidney conditions, and all other medications, particularly those for infections, as interactions are possible. This medication is contraindicated during pregnancy and breastfeeding; reliable contraception for both partners is essential throughout treatment.
Primary Ingredients of Pazolong 400mg Tablet
No text was provided to rewrite. Please provide the text you want me to rephrase.
Uses of Pazolong 400mg Tablet
Renal cell carcinoma and soft tissue sarcoma.
Major Benefits of Pazolong 400mg Tablet:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and timeframe. Ingest the 400mg Pazolong tablet whole; avoid chewing, crushing, or fracturing it. Administer on an empty stomach.
Common Side effects of Pazolong 400mg Tablet:
- Headache
- Nausea
- Vomiting
- Musculoskeletal (bone, muscle or joint) pain
- Fatigue
- Change in color of hair
- Diarrhea
- High blood pressure
- Decreased appetite
- Weight loss
- Taste change
- Abnormal skin pigmentation
- Hair discoloration
- Tumor pain
- Breathlessness
How to use Pazolong 400mg Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the 400mg Pazolong Tablet whole; avoid chewing, crushing, or fracturing it. Administer on an empty stomach.
How Pazolong 400mg Tablet works:
Pazolong 400mg tablets are an anti-neoplastic agent. Their mechanism of action involves targeting and blocking tyrosine kinase enzyme receptors, crucial for cancerous cell multiplication. Additionally, they curtail the development of tumor vasculature, thereby hindering tumor growth and progression.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Pazolong 400mg Tablets may pose unknown risks. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Using Pazolong 400mg tablets during pregnancy carries a confirmed risk to the fetus. Therefore, it's contraindicated. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Always seek medical advice.
Breast feedingUNSAFE
Lactation and the use of 400mg Pazolong tablets are incompatible due to potential infant toxicity.
DrivingUNSAFE
Taking a Pazolong 400mg Tablet might reduce attentiveness, impair vision, and cause drowsiness or dizziness. Refrain from driving if you experience these effects.
KidneySAFE IF PRESCRIBED
Pazolong 400mg tablets are considered safe for patients with impaired renal function. No dosage modification is necessary for Pazolong 400mg tablets in such patients.
LiverCAUTION
Patients with liver impairment should exercise caution when using Pazolong 400mg tablets; dosage modification may be necessary. A physician's consultation is recommended. Pazolong 400mg tablets are contraindicated for individuals with moderate to severe hepatic dysfunction.
What if you forget to take Pazolong 400mg Tablet :
NA
Facts to Know About Pazolong 400mg Tablet
| Label | Value |
|---|---|
| Chemical Type | Diarylalkylamines |
| Developing Habits | No. |
| Treatment Category | Cancer Therapeutics |
| Actions | Kinase inhibitors targeting tyrosine |
3,018 People bought this recently
